FIELD: medicine.
SUBSTANCE: method involves preliminary infecting experimental animals with human blastocyst suspension. 1.0 ml of the mixture is introduced into oral cavity in concentration of 106-107/ml by means of graduated syringe. Ligature is placed on inferior mesenterial artery for 60 s.
EFFECT: improved reproducibility; enhanced effectiveness in estimating microorganism role in large intestine infection development.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REPRODUCING GASTRIC ULCER AT THE BACKGROUND OF EXPERIMENTAL BLASTOCYSTOSIS | 2002 |
|
RU2239236C2 |
| METHOD FOR INFECTING EXPERIMENTAL ANIMALS WITH BLASTOCYSTS | 2002 |
|
RU2224465C1 |
| METHOD OF DETERMINING PROTOZOA BLASTOCYSTIS spp WITH DIFFERENT DEGREES OF VIRULENCE | 2012 |
|
RU2520742C1 |
| METHOD FOR DIAGNOSTICS OF BLASTOCYSTIS HOMINIS INVASION BY BIOPSY MATERIALS | 2021 |
|
RU2780603C1 |
| METHOD FOR SIMULATING OF ULCERATIVE COLITIS | 2015 |
|
RU2604044C1 |
| DIAGNOSTIC TECHNIQUE FOR INTESTINAL NECROSIS ACCOMPANYING MESENTERIC ISCHEMIA EXPERIMENTALLY | 2014 |
|
RU2552338C1 |
| METHOD OF TREATING CHRONIC INFLAMMATORY BOWEL DISEASES | 2010 |
|
RU2431489C1 |
| METHOD TO DETECT GENES THAT DETERMINE ADHESINS, HEMOLYSINS, MANNOSE-RESISTANT HAEMAGGLUTININS IN GENITAL STRAINS OF Escherichia coli | 2012 |
|
RU2483114C1 |
| METHOD FOR SIMULATING BLV INFECTION IN EXPERIMENTAL ANIMALS | 2020 |
|
RU2740470C1 |
| HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
